Global Prostate Cancer Diagnosis and Treatment Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Prostate Cancer Diagnosis and Treatment Revenue
• 1.4 Market by Type
  • 1.4.1 Global Prostate Cancer Diagnosis and Treatment Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Prostate specific antigen test (PSA)
  • 1.4.3 Digital rectal exam (DRE)
• 1.5 Market by Application
  • 1.5.1 Global Prostate Cancer Diagnosis and Treatment Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Diagnostic clinics
  • 1.5.4 Research centers
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Prostate Cancer Diagnosis and Treatment Market Perspective (2015-2026)
• 2.2 Global Prostate Cancer Diagnosis and Treatment Growth Trends by Regions
  • 2.2.1 Prostate Cancer Diagnosis and Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Prostate Cancer Diagnosis and Treatment Historic Market Share by Regions (2015-2020)
  • 2.2.3 Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Prostate Cancer Diagnosis and Treatment Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Prostate Cancer Diagnosis and Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Prostate Cancer Diagnosis and Treatment Players by Market Size
  • 3.1.1 Global Top Prostate Cancer Diagnosis and Treatment Players by Revenue (2015-2020)
  • 3.1.2 Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Prostate Cancer Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Prostate Cancer Diagnosis and Treatment Market Concentration Ratio
  • 3.2.1 Global Prostate Cancer Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnosis and Treatment Revenue in 2019
• 3.3 Prostate Cancer Diagnosis and Treatment Key Players Head office and Area Served
• 3.4 Key Players Prostate Cancer Diagnosis and Treatment Product Solution and Service
• 3.5 Date of Enter into Prostate Cancer Diagnosis and Treatment Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Prostate Cancer Diagnosis and Treatment Historic Market Size by Type (2015-2020)
• 4.2 Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Prostate Cancer Diagnosis and Treatment Market Size by Application (2015-2020)
• 5.2 Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Prostate Cancer Diagnosis and Treatment Market Size (2015-2020)
• 6.2 Prostate Cancer Diagnosis and Treatment Key Players in North America (2019-2020)
• 6.3 North America Prostate Cancer Diagnosis and Treatment Market Size by Type (2015-2020)
• 6.4 North America Prostate Cancer Diagnosis and Treatment Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Prostate Cancer Diagnosis and Treatment Market Size (2015-2020)
• 7.2 Prostate Cancer Diagnosis and Treatment Key Players in Europe (2019-2020)
• 7.3 Europe Prostate Cancer Diagnosis and Treatment Market Size by Type (2015-2020)
• 7.4 Europe Prostate Cancer Diagnosis and Treatment Market Size by Application (2015-2020)

8 China

• 8.1 China Prostate Cancer Diagnosis and Treatment Market Size (2015-2020)
• 8.2 Prostate Cancer Diagnosis and Treatment Key Players in China (2019-2020)
• 8.3 China Prostate Cancer Diagnosis and Treatment Market Size by Type (2015-2020)
• 8.4 China Prostate Cancer Diagnosis and Treatment Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Prostate Cancer Diagnosis and Treatment Market Size (2015-2020)
• 9.2 Prostate Cancer Diagnosis and Treatment Key Players in Japan (2019-2020)
• 9.3 Japan Prostate Cancer Diagnosis and Treatment Market Size by Type (2015-2020)
• 9.4 Japan Prostate Cancer Diagnosis and Treatment Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Prostate Cancer Diagnosis and Treatment Market Size (2015-2020)
• 10.2 Prostate Cancer Diagnosis and Treatment Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Prostate Cancer Diagnosis and Treatment Market Size by Type (2015-2020)
• 10.4 Southeast Asia Prostate Cancer Diagnosis and Treatment Market Size by Application (2015-2020)

11 India

• 11.1 India Prostate Cancer Diagnosis and Treatment Market Size (2015-2020)
• 11.2 Prostate Cancer Diagnosis and Treatment Key Players in India (2019-2020)
• 11.3 India Prostate Cancer Diagnosis and Treatment Market Size by Type (2015-2020)
• 11.4 India Prostate Cancer Diagnosis and Treatment Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Prostate Cancer Diagnosis and Treatment Market Size (2015-2020)
• 12.2 Prostate Cancer Diagnosis and Treatment Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Prostate Cancer Diagnosis and Treatment Market Size by Type (2015-2020)
• 12.4 Central & South America Prostate Cancer Diagnosis and Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Abbott Laboratories
  • 13.1.1 Abbott Laboratories Company Details
  • 13.1.2 Abbott Laboratories Business Overview
  • 13.1.3 Abbott Laboratories Prostate Cancer Diagnosis and Treatment Introduction
  • 13.1.4 Abbott Laboratories Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020))
  • 13.1.5 Abbott Laboratories Recent Development
• 13.2 AbbVie
  • 13.2.1 AbbVie Company Details
  • 13.2.2 AbbVie Business Overview
  • 13.2.3 AbbVie Prostate Cancer Diagnosis and Treatment Introduction
  • 13.2.4 AbbVie Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
  • 13.2.5 AbbVie Recent Development
• 13.3 Active Biotech
  • 13.3.1 Active Biotech Company Details
  • 13.3.2 Active Biotech Business Overview
  • 13.3.3 Active Biotech Prostate Cancer Diagnosis and Treatment Introduction
  • 13.3.4 Active Biotech Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
  • 13.3.5 Active Biotech Recent Development
• 13.4 Amgen
  • 13.4.1 Amgen Company Details
  • 13.4.2 Amgen Business Overview
  • 13.4.3 Amgen Prostate Cancer Diagnosis and Treatment Introduction
  • 13.4.4 Amgen Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
  • 13.4.5 Amgen Recent Development
• 13.5 Astellas Pharma
  • 13.5.1 Astellas Pharma Company Details
  • 13.5.2 Astellas Pharma Business Overview
  • 13.5.3 Astellas Pharma Prostate Cancer Diagnosis and Treatment Introduction
  • 13.5.4 Astellas Pharma Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
  • 13.5.5 Astellas Pharma Recent Development
• 13.6 AstraZeneca
  • 13.6.1 AstraZeneca Company Details
  • 13.6.2 AstraZeneca Business Overview
  • 13.6.3 AstraZeneca Prostate Cancer Diagnosis and Treatment Introduction
  • 13.6.4 AstraZeneca Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
  • 13.6.5 AstraZeneca Recent Development
• 13.7 Bavarian Nordic
  • 13.7.1 Bavarian Nordic Company Details
  • 13.7.2 Bavarian Nordic Business Overview
  • 13.7.3 Bavarian Nordic Prostate Cancer Diagnosis and Treatment Introduction
  • 13.7.4 Bavarian Nordic Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
  • 13.7.5 Bavarian Nordic Recent Development
• 13.8 Bayer
  • 13.8.1 Bayer Company Details
  • 13.8.2 Bayer Business Overview
  • 13.8.3 Bayer Prostate Cancer Diagnosis and Treatment Introduction
  • 13.8.4 Bayer Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
  • 13.8.5 Bayer Recent Development
• 13.9 Bristol-Myers Squibb
  • 13.9.1 Bristol-Myers Squibb Company Details
  • 13.9.2 Bristol-Myers Squibb Business Overview
  • 13.9.3 Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Introduction
  • 13.9.4 Bristol-Myers Squibb Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
  • 13.9.5 Bristol-Myers Squibb Recent Development
• 13.10 Dendreon
  • 13.10.1 Dendreon Company Details
  • 13.10.2 Dendreon Business Overview
  • 13.10.3 Dendreon Prostate Cancer Diagnosis and Treatment Introduction
  • 13.10.4 Dendreon Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
  • 13.10.5 Dendreon Recent Development
• 13.11 Endo
  • 10.11.1 Endo Company Details
  • 10.11.2 Endo Business Overview
  • 10.11.3 Endo Prostate Cancer Diagnosis and Treatment Introduction
  • 10.11.4 Endo Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
  • 10.11.5 Endo Recent Development
• 13.12 Ferring Pharmaceuticals
  • 10.12.1 Ferring Pharmaceuticals Company Details
  • 10.12.2 Ferring Pharmaceuticals Business Overview
  • 10.12.3 Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Introduction
  • 10.12.4 Ferring Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
  • 10.12.5 Ferring Pharmaceuticals Recent Development
• 13.13 GE Healthcare
  • 10.13.1 GE Healthcare Company Details
  • 10.13.2 GE Healthcare Business Overview
  • 10.13.3 GE Healthcare Prostate Cancer Diagnosis and Treatment Introduction
  • 10.13.4 GE Healthcare Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
  • 10.13.5 GE Healthcare Recent Development
• 13.14 GSK
  • 10.14.1 GSK Company Details
  • 10.14.2 GSK Business Overview
  • 10.14.3 GSK Prostate Cancer Diagnosis and Treatment Introduction
  • 10.14.4 GSK Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
  • 10.14.5 GSK Recent Development
• 13.15 Ipsen
  • 10.15.1 Ipsen Company Details
  • 10.15.2 Ipsen Business Overview
  • 10.15.3 Ipsen Prostate Cancer Diagnosis and Treatment Introduction
  • 10.15.4 Ipsen Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
  • 10.15.5 Ipsen Recent Development
• 13.16 Johnson & Johnson
  • 10.16.1 Johnson & Johnson Company Details
  • 10.16.2 Johnson & Johnson Business Overview
  • 10.16.3 Johnson & Johnson Prostate Cancer Diagnosis and Treatment Introduction
  • 10.16.4 Johnson & Johnson Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
  • 10.16.5 Johnson & Johnson Recent Development
• 13.17 Pfizer
  • 10.17.1 Pfizer Company Details
  • 10.17.2 Pfizer Business Overview
  • 10.17.3 Pfizer Prostate Cancer Diagnosis and Treatment Introduction
  • 10.17.4 Pfizer Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
  • 10.17.5 Pfizer Recent Development
• 13.18 Sanofi
  • 10.18.1 Sanofi Company Details
  • 10.18.2 Sanofi Business Overview
  • 10.18.3 Sanofi Prostate Cancer Diagnosis and Treatment Introduction
  • 10.18.4 Sanofi Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
  • 10.18.5 Sanofi Recent Development
• 13.19 Siemens Healthineers
  • 10.19.1 Siemens Healthineers Company Details
  • 10.19.2 Siemens Healthineers Business Overview
  • 10.19.3 Siemens Healthineers Prostate Cancer Diagnosis and Treatment Introduction
  • 10.19.4 Siemens Healthineers Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
  • 10.19.5 Siemens Healthineers Recent Development
• 13.20 Takeda
  • 10.20.1 Takeda Company Details
  • 10.20.2 Takeda Business Overview
  • 10.20.3 Takeda Prostate Cancer Diagnosis and Treatment Introduction
  • 10.20.4 Takeda Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
  • 10.20.5 Takeda Recent Development
• 13.21 Teva Pharmaceutical
  • 10.21.1 Teva Pharmaceutical Company Details
  • 10.21.2 Teva Pharmaceutical Business Overview
  • 10.21.3 Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Introduction
  • 10.21.4 Teva Pharmaceutical Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
  • 10.21.5 Teva Pharmaceutical Recent Development
• 13.22 Tolmar Pharmaceuticals
  • 10.22.1 Tolmar Pharmaceuticals Company Details
  • 10.22.2 Tolmar Pharmaceuticals Business Overview
  • 10.22.3 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Introduction
  • 10.22.4 Tolmar Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Treatment Business (2015-2020)
  • 10.22.5 Tolmar Pharmaceuticals Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer